Join the club for FREE to access the whole archive and other member benefits.

Bringing regenerative technology to patients

04-Aug-2020

Key points from article :

Wake Forest Institute of Regenerative Medicine has been at the forefront of tissue and organ regeneration.

Dr. Anthony Atala, the institute’s Director says " As we age, we all naturally have increased fibrosis in our bodies....a major area that we are working on is how to reverse the fibrosis to start with, so you don’t end up with kidney failure, or heart failure, or liver failure.”

The institute also works in the area of gene editing with tools like CRISPR.

Wake Forest has gained recognition for its work in 3D bioprinting in recent years.

For commercialization purposes, the institute has a “generator”, to bring technologies, in advanced preclinical or post clinical trial stages to market.

They also own a regulatory team along with an FDA-compliant manufacturing facility, to proceed through clinical trials themselves.

A successful commercial venture that has come out of Wake Forest, is Twin City Bio an established contract manufacturing organization.

Commercialization of tissue and organ regeneration process for clinical use

Mentioned in this article:

Tap on icon for description, click on resource name for more details.

Academic

Director of Wake Forest Institute for Regenerative Medicine.

Company

Manufacturers of Cell therapy products

Institute

Research institute affiliated with Wake Forest School of Medicine.